Oxidative stress-associated rise of hepatic protein glycation increases inflammatory liver injury in uncoupling protein-2 deficient mice

Harman, 1956, Aging: a theory based on free radical and radiation chemistry, J Gerontol, 11, 298, 10.1093/geronj/11.3.298 Miquel, 1980, Mitochondrial role in cell aging, Exp Gerontol, 15, 575, 10.1016/0531-5565(80)90010-8 Raha, 2001, Mitochondria, oxygen free radicals, and apoptosis, Am J Med Genet, 106, 62, 10.1002/ajmg.1398 Skulachev, 1998, Uncoupling: new approaches to an old problem of bioenergetics, Biochim Biophys Acta, 1363, 100, 10.1016/S0005-2728(97)00091-1 Echtay, 2002, Superoxide activates mitochondrial uncoupling proteins, Nature, 415, 96, 10.1038/415096a Boss, 2000, Uncoupling proteins 2 and 3: potential regulators of mitochondrial energy metabolism, Diabetes, 49, 143, 10.2337/diabetes.49.2.143 Mattiasson, 2003, Uncoupling protein-2 prevents neuronal death and diminishes brain dysfunction after stroke and brain trauma, Nat Med, 9, 1062, 10.1038/nm903 Teshima, 2003, Uncoupling protein-2 overexpression inhibits mitochondrial death pathway in cardiomyocytes, Circ Res, 93, 192, 10.1161/01.RES.0000085581.60197.4D Nègre-Salvayre, 1997, A role for uncoupling protein-2 as a regulator of mitochondrial hydrogen peroxide generation, FASEB J, 11, 809, 10.1096/fasebj.11.10.9271366 Duval, 2002, Increased reactive oxygen species production with antisense oligonucleotides directed against uncoupling protein 2 in murine endothelial cells, Biochem Cell Biol, 80, 757, 10.1139/o02-158 Brownlee, 1994, Glycation and diabetic complications, Diabetes (Lilly Lecture, 1994), 43, 836 Schmidt, 2007, Cell cycle related signaling in Neuro2a cells proceeds via the receptor for advanced glycation end products, J Neural Transm, 114, 1413, 10.1007/s00702-007-0770-0 Bucala, 1994, Modification of low density lipoprotein by advanced glycation end products contributes to the dyslipidemia of diabetes and renal insufficiency, Proc Natl Acad Sci USA, 91, 9441, 10.1073/pnas.91.20.9441 Takeuchi, 2004, Involvement of advanced glycation end-products (AGEs) in Alzheimer's disease, Curr Alzheimer Res, 1, 39, 10.2174/1567205043480582 Araki, 1992, Immunochemical evidence for the presence of advanced glycation end products in human lens proteins and its positive correlation with aging, J Biol Chem, 267, 10211, 10.1016/S0021-9258(19)50004-7 Brownlee, 1995, Advanced protein glycosylation in diabetes and aging, Annu Rev Med, 46, 223, 10.1146/annurev.med.46.1.223 Kume, 1995, Immunohistochemical and ultrastructural detection of advanced glycation end products in atherosclerotic lesions of human aorta with a novel specific monoclonal antibody, Am J Pathol, 147, 654 Thornalley, 2003, Glyoxalase I—structure, function and a critical role in the enzymatic defence against glycation, Biochem Soc Trans, 31, 1343, 10.1042/bst0311343 Kuhla, 2006, Age-dependent changes of glyoxalase I expression in human brain, Neurobiol Aging, 27, 815, 10.1016/j.neurobiolaging.2005.04.006 Smedsrød, 1997, Advanced glycation end products are eliminated by scavenger-receptor-mediated endocytosis in hepatic sinusoidal Kupffer and endothelial cells, Biochem J, 322, 567, 10.1042/bj3220567 Ito, 2007, Age-related changes in the hepatic microcirculation in mice, Exp Gerontol, 42, 789, 10.1016/j.exger.2007.04.008 Neeper, 1992, Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins, J Biol Chem, 267, 14998, 10.1016/S0021-9258(18)42138-2 Schmidt, 1994, Cellular receptors for advanced glycation end products. Implications for induction of oxidant stress and cellular dysfunction in the pathogenesis of vascular lesions, Arterioscler Thromb, 14, 1521, 10.1161/01.ATV.14.10.1521 Thornalley, 1998, Cell activation by glycated proteins. AGE receptors, receptor recognition factors and functional classification of AGEs, Cell Mol Biol, 44, 1013 Schmidt, 2000, The biology of the receptor for advanced glycation end products and its ligands, Biochim Biophys Acta, 1498, 99, 10.1016/S0167-4889(00)00087-2 Bierhaus, 1997, Advanced glycation end product-induced activation of NF-kappaB is suppressed by alpha-lipoic acid in cultured endothelial cells, Diabetes, 46, 1481, 10.2337/diab.46.9.1481 Stern, 2002, Receptor for advanced glycation end products: a multiligand receptor magnifying cell stress in diverse pathologic settings, Adv Drug Deliv Rev, 54, 615, 10.1016/S0169-409X(02)00160-6 Park, 1998, Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation end products, Nat Med, 4, 1025, 10.1038/2012 Freudenberg, 1986, Requirement for lipopolysaccharide-responsive macrophages in galactosamine-induced sensitization to endotoxin, Infect Immun, 51, 891, 10.1128/iai.51.3.891-895.1986 Arsenijevic, 2000, Disruption of the uncoupling protein-2 gene in mice reveals a role in immunity and reactive oxygen species production, Nat Genet, 26, 435, 10.1038/82565 Eipel, 2007, Antileukoproteinase protects against hepatic inflammation, but not apoptosis in the response of D-galactosamine-sensitized mice to lipopolysaccharide, Br J Pharmacol, 151, 406, 10.1038/sj.bjp.0707230 Kuhla, 2008, Hepatocellular apoptosis is mediated by TNFalpha-dependent Fas/FasLigand cytotoxicity in a murine model of acute liver failure, Apoptosis, 13, 1427, 10.1007/s10495-008-0269-7 Cataldegirmen, 2005, RAGE limits regeneration after massive liver injury by coordinated suppression of TNF-alpha and NF-kappaB, J Exp Med, 201, 473, 10.1084/jem.20040934 Wautier, 1996, Receptor-mediated endothelial cell dysfunction in diabetic vasculopathy. Soluble receptor for advanced glycation end products blocks hyperpermeability in diabetic rats, J Clin Invest, 97, 238, 10.1172/JCI118397 Allen, 1993, Purification and characterisation of glyoxalase II from human red blood cells, Eur J Biochem, 213, 1261, 10.1111/j.1432-1033.1993.tb17877.x Horiuchi, 1991, Immunochemical approach to characterize advanced glycation end products of the Maillard reaction. Evidence for the presence of a common structure, J Biol Chem, 266, 7329, 10.1016/S0021-9258(20)89449-6 Ghavami, 2008, S100A8/A9 at low concentration promotes tumor cell growth via RAGE ligation and MAP kinase-dependent pathway, J Leukoc Biol, 83, 1484, 10.1189/jlb.0607397 Miyata, 1996, Identification of pentosidine as a native structure for advanced glycation end products in beta-2-microglobulin-containing amyloid fibrils in patients with dialysis-related amyloidosis, Proc Natl Acad Sci USA, 93, 2353, 10.1073/pnas.93.6.2353 Sastre, 1996, Aging of the liver: age-associated mitochondrial damage in intact hepatocytes, Hepatology, 24, 1199, 10.1002/hep.510240536 Rolo, 2006, Diabetes and mitochondrial function: role of hyperglycemia and oxidative stress, Toxicol Appl Pharmacol, 212, 167, 10.1016/j.taap.2006.01.003 Chagnon, 1995, Distribution of brain cytochrome oxidase activity in various neurodegenerative diseases, Neuroreport, 6, 711, 10.1097/00001756-199503270-00002 Beckman, 1998, The free radical theory of aging matures, Physiol Rev, 78, 547, 10.1152/physrev.1998.78.2.547 Navarro, 2007, The mitochondrial energy transduction system and the aging process, Am J Physiol Cell Physiol, 292, C670, 10.1152/ajpcell.00213.2006 Basta, 2004, Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes, Cardiovasc Res, 63, 582, 10.1016/j.cardiores.2004.05.001 Cooper, 2004, Importance of advanced glycation end products in diabetes-associated cardiovascular and renal disease, Am J Hypertens, 17, 31S, 10.1016/j.amjhyper.2004.08.021 Stitt, 2004, Advanced glycation and advanced lipoxidation: possible role in initiation and progression of diabetic retinopathy, Curr Pharm Des, 10, 3349, 10.2174/1381612043383124 Sebeková, 2002, Markedly elevated levels of plasma advanced glycation end products in patients with liver cirrhosis—amelioration by liver transplantation, J Hepatol, 36, 66, 10.1016/S0168-8278(01)00232-X Stolzing, 2006, Degradation of glycated bovine serum albumin in microglial cells, Free Radic Biol Med, 40, 1017, 10.1016/j.freeradbiomed.2005.10.061 Takata, 1988, Endocytic uptake of nonenzymatically glycosylated proteins is mediated by a scavenger receptor for aldehyde-modified proteins, J Biol Chem, 263, 14819, 10.1016/S0021-9258(18)68112-8 Yamagishi, 1995, Receptor-mediated toxicity to pericytes of advanced glycosylation end products: a possible mechanism of pericyte loss in diabetic microangiopathy, Biochem Biophys Res Commun, 213, 681, 10.1006/bbrc.1995.2185 Tsuji, 1998, Ribozyme targeting of receptor for advanced glycation end products in mouse mesangial cells, Biochem Biophys Res Commun, 245, 583, 10.1006/bbrc.1998.8489 Liliensiek, 2004, Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response, J Clin Invest, 113, 1641, 10.1172/JCI200418704 Hiwatashi, 2008, A novel function of the receptor for advanced glycation end-products (RAGE) in association with tumorigenesis and tumor differentiation of HCC, Ann Surg Oncol, 15, 923, 10.1245/s10434-007-9698-8 Ekong, 2006, Blockade of the receptor for advanced glycation end products attenuates acetaminophen-induced hepatotoxicity in mice, J Gastroenterol Hepatol, 21, 682, 10.1111/j.1440-1746.2006.04225.x Zeng, 2004, Blockade of receptor for advanced glycation end product (RAGE) attenuates ischemia and reperfusion injury to the liver in mice, Hepatology, 39, 422, 10.1002/hep.20045 Basta, 2002, Advanced glycation end products activate endothelium through signal-transduction receptor RAGE: a mechanism for amplification of inflammatory responses, Circulation, 105, 816, 10.1161/hc0702.104183 De la Fuente, 2008, Role of neuroimmunomodulation in aging, Neuroimmunomodulation, 15, 213, 10.1159/000156465 Taguchi, 2000, Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases, Nature, 405, 354, 10.1038/35012626